IRCT20201003048904N2已完成未知
: Evaluation of the effect of spironolactone and DDP4 inhibitors on treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2 or COVID-19)
Boushehr University of Medical Sciences0 个研究点目标入组 200 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20 years 至 no limit(—)
- 性别
- All
入选标准
- •admitted patients in Bushehr's Shohadaye_Khalije_Fars hospital due to COVID19 diagnosis confirmed by Rt-PCR
- •age equal or more than 20
- •Male and female OPD patients with confirmed or probable SARS-CoV-2 infection according to WHO and CDC definitions referred to Motahari Clinic.
排除标准
- •positive history of spironolactone or DPP4 inhibitor consumption
- •contraindications for drug intervention consumption (Plasma Acid/base, Electrolyte or Glucose abnormalities)
- •hypersensitivity to drugs
- •patient dissatisfaction
- •intubation and mechanical ventilation at admission onset
研究者
相似试验
已完成
4 期
The effect of the low-dose spironolactone in post adolescent acne: a randomized, double-blind, placebo-controlled trial.acne vulgaris in women who age from 25ᇁ years oldspironolactonepostadolescent acneTCTR20190417004Faculty of Medicine, Chulalongkorn University62
已完成
2 期
The effect of spironolactone in treatment of heart failureHeart Failure.Congestive heart failureIRCT2015101924597N1Vice chancellor for research of Iran university of medical sciences60
招募中
3 期
Comparison between the effects of spironolactone and eplerenone in the treatment of heart failureIRCT20130422013090N4Sari University of Medical Sciences70
招募中
2 期
Comparing the effectiveness of spironolactone solution with clindamycin solution in patients with acneMild to moderate acne vulgaris.Acne vulgarisL70.0IRCT20120524009844N12Tabriz University of Medical Sciences60
已完成
3 期
Effect of Spirnolactone in heart failureHeart failure.congestive heart failureIRCT2015010520563N1Ahwaz Jundishapur University of Medical Science100
